Search

Summary: Objective: To evaluate the efficacy and safety associated with use of a 589‐nm solid‐state laser for treatment of facial erythema. Methods: A prospective, IRB‐approved study was conducted. Participants who were interested in treatment for facial erythema were recruited. They received four monthly treatments with the 589‐nm laser. Erythema of the right and left face was graded on a scale of 0‐4, 4 being most severe, by both investigators and participants prior to each treatment and at follow‐up. Safety was assessed by any reported side effects. Results: Twenty‐four participants enrolled in the study, 16 women (67%) and 8 men (33%), with an average age of 51.1 years. Investigator grades showed a statistically significant improvement in erythema of 31% for both the right and left face. Participant grades showed a statistically significant improvement in erythema of 23.2% for the right face and 22.8% for the left face. Side effects were limited to transient erythema posttreatment. Conclusion: A 589‐nm solid‐state laser achieved a modest improvement in facial erythema when evaluating results 1 month after four monthly treatments. No major safety issues were reported. [ABSTRACT FROM AUTHOR]